Neutralizing monoclonal antibodies engineered from three humans infected with Zika virus protected non-human primates from contracting the mosquito-borne disease, according to a new study published in Science Translational Medicine.
After a lag in reporting last week, the Saudi Arabian Ministry of Health (MOH) updated it information on MERS-CoV cases over the weekend, noting three new cases since the agency last reported on Sep 25.
One genetic mutation in 2013 allowed the virus to become more infective and cause birth defects, a new study suggests.
The antibody protected both adult and fetal mice against Zika infection.
A single dose of the live-attenuated vaccine prevents transmission to the offspring of pregnant mice, as well as preventing testicular damage in male mice.
About 75% of counties on the US mainland have suitable habitat for Aedes mosquitoes, CDC researchers say.
EpiVax, Inc., a vaccine development and immune engineering company based in Providence, R.I., yesterday announced it is part of collaboration supported by a $5.8 million award from the National Institutes of Health (NIH) to develop a new type of vaccine against H7N9 avian influenza.
Italy has now confirmed 14 cases of locally acquired chikungunya, 6 of them in Rome, the World Health Organization (WHO) said in a Sep 15 statement.
Pregnant women who received the pandemic H1N1 influenza vaccine in 2009 or 2010 were no more likely to have adverse birth outcomes than women who received the seasonal flu shot at the time, according to a study published yesterday in Vaccine.
Tom Frieden, MD, MPH, who stepped down as the director of the US Centers for Disease Control and Prevention (CDC) at the end of the Obama administration, today announced the launch of a $225 million initiative to combat infectious disease outbreaks and heart disease and stroke throughout the world, according to media reports.
